AN OPEN-LABEL, DOSE-FINDING, AND COHORT-EXPSANSION PHASE I STUDY EVALUATING SAFETY AND EFFICACY OF INCB050465 IN COMBINATION WITH BENDAMUSTINE AND OBINUTUZUMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102)
2016-002829-11LINFOMA FOLICULARFundación Jiménez DíazInvestigador: CORDOBA MASCUÑANO RAUL
